长按识别图中二维码
阅读 “Global Forum” 2024 七月刊
Global Forum
July 2024
FEATURE ARTICLES
Survey: Patient Attitudes Toward Participation and Use of Digital Technologies in Clinical Research
Implementing Patient-Reported Outcomes in Cancer Clinical Trials
A Closer Look at FDA’s Draft Guidance and a Call to Action
Enabling Platform Trials with Master Protocols: How EU-PEARL and TransCelerate BioPharma Created a Global Template
Talking Statistics: Why Clear Communications and Close Collaborations are Important in Cross-Functional Teams Engaged in Clinical Research
How Did We Get Here? A History of eCTD and Prospects for eCTD 4.0
How to Communicate Unapproved Uses Without Breaking the Law
Around the Globe
Making Global Reliance a Reality for Post-Approval Changes of Medicines and Vaccines
The African Medicines Agency: Building a New Gold Standard in Regulatory Excellence
Insights from DIA Europe 2024
New TGA Head Welcomes Emerging Science and Therapies to Australia
Evolving Policies and Use of RWE in Regulatory Decisions in China
Clinical Trials in Wartime: One Patient’s Journey to Survival
We Are DIA
DIA Congratulates New 2024 Fellows and Global Inspire Award Winners
电子月刊“Global Forum”，以全球为视野，由资深行业领袖担任区域编辑，为读者呈现最专业、最即时的行业信息与专家评议。提供全球医疗产品关于研发、监管等方面的专家见解，其中包括思想领袖采访与年会的专题摘要。
扫码阅读Global Forum
阅读链接：
https://www.diaglobal.org/en/resources/publications/global-forum
迪亚恩近期会议/培训
| |||
| |||
| |||
| |||
| |||
| |||
| |||
|
关于DIA
DIA是一个全球化、跨学科的国际性学术平台，在中立的环境中，融合医药研发领域全行业的意见领袖，探讨当前研发的技术问题，提升专业能力，以及催化行业共识，在全球医药研发领域享有很高的声誉。
